Physiology and antibiotic susceptibility of Staphylococcus aureus small colony variants

Microbial Drug Resistance

Volumn 8, Issue 4, 2002, Pages 253-260

  Baumert, Nicole ^a   Von Eiff, Christof ^b   Schaaff, Franziska ^a   Peters, Georg ^b   Proctor, Richard A ^c   Sahl, Hans Georg ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; AMIKACIN; AMINOGLYCOSIDE DERIVATIVE; ANTIBIOTIC AGENT; BACTERIAL PROTEIN; BUFFER; CLINDAMYCIN; ERYTHROMYCIN; GENTAMICIN; GLUCOSE; KANAMYCIN; LACTIC ACID; MENAQUINONE; NETILMICIN; OXACILLIN; PROTEIN HEMB; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM COLONY; CONTROLLED STUDY; GLUCOSE INTAKE; NONHUMAN; NUTRIENT; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; WILD TYPE;

BACTERIA (MICROORGANISMS); STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 12244298885     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/10766290260469507     Document Type: Article

References (31)

1. Abele-Horn, M., B. Schupfner, P. Emmerling, H. Waldner, and H. Goring. 2000. Persistent wound infection after herniotomy associated with small-colony variants of Staphylococcus aureus. Infection 28:53-54.
2. Acar, J.F., F.W. Goldstein, and P. Lagrange. 1978. Human infections caused by thiamine- or menadione-requiring Staphylococcus aureus. J. Clin. Microbiol 8:142-147.
3. Balwit, J.M., P. van Langevelde, J.M. Vann, and R.A. Proctor. 1994. Gentamicin-resistant menadione and hemin auxotrophic Staphylococcus aureus persist within cultured endothelial cells. J. Infect. Dis. 170:1033-1037.
4. Bierbaum, G., and H.G. Sahl. 1987. Autolytic system of Staphylococcus simulans 22: Influence of cationic peptides on activity of N-acetylmuramoyl-L-alanine amidase. J. Bacteriol. 169:5452-5458.
5. Eisenberg, E.S., L.J. Mandel, H.R. Kaback, and M.H. Miller. 1984. Quantitative association between electrical potential across the cytoplasmic membrane and early gentamicin uptake and killing in Staphylococcus aureus. J. Bacteriol. 157:863-867.
6. Kolle, W., and H. Hetsch. 1911. Die Experimentelle Bakteriologie und die Infektionskrankheiten mit Besonderer Berücksichtigung der Immunitätslehre. Urban und Schwarzenberg, Berlin.
7. Koo, S.P., A.S. Bayer, H.G. Sahl, R.A. Proctor, and M.R. Yeaman. 1996. Staphylocidal action of thrombin-induced platelet microbicidal protein is not solely dependent on transmembrane potential. Infect. Immun. 64:1070-1074.
8. Koo, S.P., M.R. Yeaman, and A.S. Bayer. 1996. Staphylocidal action of thrombin-induced platelet microbicidal protein is influenced by microenvironment and target cell growth phase. Infect. Immun. 64:3758-3764.
9. Kordel, M., R. Benz, and H.G. Sahl. 1988. Mode of action of the staphylococcinlike peptide Pep 5: Voltage-dependent depolarization of bacterial and artificial membranes. J. Bacteriol. 170:84-88.
10. Kornblum, J., B. Kreiswirth, S. Projan, H.F. Ross, and R.P. Novick. 1990. agr, a policistronic locus regulating exoprotein synthesis in Staphylococcus aureus. In R.P. Novick (ed.), Molecular Biology of the Staphylococci. VCH, New York, pp. 373-402.
11. Mates, S.M., E.S. Eisenberg, L.J. Mandel, L. Patel, H.R. Kaback, and M.H. Miller. 1982. Membrane potential and gentamicin uptake in Staphylococcus aureus. Proc. Natl. Acad. Sci. USA 79:6693-6697.
12. McNamara, P.J., and R.A. Proctor. 2000. Staphylococcus aureus small colony variants, electron transport and persistent infections. Int. J. Antimicrobial Agents 14:117-122.
13. Musher, D.M., R.E. Baughn, G.B. Templeton, and J.N. Minuth. 1977. Emergence of variant forms of Staphylococcus aureus after exposure to gentamicin and infectivity of the variants in experimental animals. J. Infect. Dis. 136:360-369.
14. Novick, R.P. 1963. Properties of a cryptic high-frequency transducing phage in Staphylococcus aureus. Virology 33:155-166.
15. Peschel, A., M. Otto, R.W. Jack, H. Kalbacher, G. Jung, and F. Götz. 1999. Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides. J. Biol. Chem. 274:8405-8410.
16. Proctor, R.A. 1994. Microbial pathogenic factors: Small-colony-variants. In A.L. Bisno and F.A. Waldvogel (ed.), Infections Associated with Indwelling Medial Devices. 2nd Ed. American Society for Microbiology, Washington, DC, pp. 79-89.
17. Proctor, R.A., J.M. Balwit, and O. Vesga. 1994. Variant subpopulations of Staphylococcus aureus as cause of persistent and recurrent infections. Infect. Agents Dis. 3:302-312.
18. Proctor, R.A., B. Kahl, C. von Eiff, P.E. Vaudaux, D.P. Lew, and G. Peters. 1998. Staphylococcal small colony variants have novel mechanisms for antibiotic resistance. Clin. Infect. Dis 27(Suppl 1):S68-S74.
19. Proctor, R.A., and G. Peters. 1998. Small colony variants in staphylococcal infections: Diagnostic and therapeutic implications. Clin. Infect. Dis 27:419-422.
20. Proctor, R.A., P. van Langevelde, M. Kristjansson, J.N. Maslow, and R.D. Arbeit. 1995. Persistent and relapsing infections associated with small-colony variants of Staphylococcus aureus. Clin. Infect. Dis. 20:95-102.
21. Quie, P.G. 1969. Microcolonies (G-variants) of Staphylococcus aureus. Yale J. Biol. Med. 41:394-403.
22. Ruhr, E., and H.G. Sahl. 1985. Mode of action of the peptide antibiotic nisin and influence on the membrane potential of whole cells and on cytoplasmic and artificial membrane vesicles. Antimicrob. Agents Chemother. 27:841-845.
23. Sahl, H.G. 1985. Influence of the staphylococcinlike peptide Pep 5 on membrane potential of bacterial cells and cytoplasmic membrane vesicles. J. Bacteriol. 162:833-836.
24. Sahl, H.G., M. Kordel, and R. Benz. 1987. Voltage-dependent depolarization of bacterial membranes and artificial lipid bilayers by the peptide antibiotic nisin. Arch. Microbiol 149:120-124.
25. Schnitzer R.J., Camagni L.J., and Buck M. 1943. Resistance of small colony variants (G forms) of a staphylococcus toward the bacteriostatic activity of penicillin. Proc. Soc. Exp. Biol. Med. 53:75-89.
26. Shimoda, M., K. Ohki, Y. Shimamoto, and O. Kohashi. 1995. Morphology of defensin-treated Staphylococcus aureus. Infect. Immun. 63:2886-2891.
27. van de Rijn, I., and R.E. Kessler. 1980. Growth characteristics of group A streptococci in a new chemically defined medium. Infect. Immun. 27:444-448.
28. Verklin, R.M., and G.L. Mandell. 1977. Alteration of effectiveness of antibiotics by anaerobiosis. J. Lab. Clin. Med. 89:65-71.
29. von Eiff, C., D. Bettin, R.A. Proctor, B. Rolauffs, N. Lindner, W. Winkelmann, and G. Peters. 1997. Recovery of small colony variants of Staphylococcus aureus following gentamicin bead placement for osteomyelitis. Clin. Infect. Dis 25:1250-1251.
30. von Eiff, C., C. Heilmann, R.A. Proctor, C. Woltz, G. Peters, and F. Götz. 1997. A site-directed Staphylococcus aureus hemB mutant is a small-colony variant which persists intracellularly. J. Bacteriol. 179:4706-4712.
31. von Eiff, C., N. Lindner, R.A. Proctor, W. Winkelmann, and G. Peters. 1998. [Development of gentamicin-resistant Small Colony Variants of S. aureus after implantation of gentamicin chains in osteomyelitis as a possible cause of recurrence]. Z. Orthop. Ihre. Grenzgeb. 136:268-271.